Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review
This study is aimed at reviewing the published literature on the prognostic role of serum procalcitonin (PCT) in COVID-19 cases. We systematically reviewed the literature available on PubMed, MEDLINE, LitCovid NLM, and WHO: to assess the utility of PCT in prognosis of coronavirus disease. Scrutiny f...
Gespeichert in:
| Veröffentlicht in: | Indian journal of critical care medicine Jg. 25; H. 1; S. 77 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
India
01.01.2021
|
| Schlagworte: | |
| ISSN: | 0972-5229 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | This study is aimed at reviewing the published literature on the prognostic role of serum procalcitonin (PCT) in COVID-19 cases.
We systematically reviewed the literature available on PubMed, MEDLINE, LitCovid NLM, and WHO: to assess the utility of PCT in prognosis of coronavirus disease. Scrutiny for eligible studies comprising articles that have evaluated the prognostic utility of PCT and data compilation was undertaken by two separate investigators. Original articles in human subjects reporting the prognostic role of PCT in adult COVID-19 patients were included. The Quality in Prognosis Studies (QUIPS) tool was utilized to assess the strength of evidence. Results were reported as narrative syntheses.
Out of the total 426 citations, 52 articles passed through screening. The quality of evidence and methodology of included studies was overall acceptable. The total sample size of the studies comprised of 15,296 COVID-19-positive subjects. Majority of the studies were from China, i.e., 40 (77%). The PCT cut-off utilized was 0.05 ng/mL by 18 (35%) studies, followed by 0.5 ng/mL by 9 (17.5%). Eighty five percent (
= 44) studies reported statistically significant association (
value < 0.05) between PCT and severity.
Procalcitonin appears as a promising prognostic biomarker of COVID-19 progression in conjunction with the clinical context.
Ahmed S, Jafri L, Hoodbhoy Z, Siddiqui I. Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review. Indian J Crit Care Med 2021;25(1):77-84. |
|---|---|
| AbstractList | This study is aimed at reviewing the published literature on the prognostic role of serum procalcitonin (PCT) in COVID-19 cases.BACKGROUNDThis study is aimed at reviewing the published literature on the prognostic role of serum procalcitonin (PCT) in COVID-19 cases.We systematically reviewed the literature available on PubMed, MEDLINE, LitCovid NLM, and WHO: to assess the utility of PCT in prognosis of coronavirus disease. Scrutiny for eligible studies comprising articles that have evaluated the prognostic utility of PCT and data compilation was undertaken by two separate investigators. Original articles in human subjects reporting the prognostic role of PCT in adult COVID-19 patients were included. The Quality in Prognosis Studies (QUIPS) tool was utilized to assess the strength of evidence. Results were reported as narrative syntheses.DATA RETRIEVALWe systematically reviewed the literature available on PubMed, MEDLINE, LitCovid NLM, and WHO: to assess the utility of PCT in prognosis of coronavirus disease. Scrutiny for eligible studies comprising articles that have evaluated the prognostic utility of PCT and data compilation was undertaken by two separate investigators. Original articles in human subjects reporting the prognostic role of PCT in adult COVID-19 patients were included. The Quality in Prognosis Studies (QUIPS) tool was utilized to assess the strength of evidence. Results were reported as narrative syntheses.Out of the total 426 citations, 52 articles passed through screening. The quality of evidence and methodology of included studies was overall acceptable. The total sample size of the studies comprised of 15,296 COVID-19-positive subjects. Majority of the studies were from China, i.e., 40 (77%). The PCT cut-off utilized was 0.05 ng/mL by 18 (35%) studies, followed by 0.5 ng/mL by 9 (17.5%). Eighty five percent (n = 44) studies reported statistically significant association (p value < 0.05) between PCT and severity.RESULTSOut of the total 426 citations, 52 articles passed through screening. The quality of evidence and methodology of included studies was overall acceptable. The total sample size of the studies comprised of 15,296 COVID-19-positive subjects. Majority of the studies were from China, i.e., 40 (77%). The PCT cut-off utilized was 0.05 ng/mL by 18 (35%) studies, followed by 0.5 ng/mL by 9 (17.5%). Eighty five percent (n = 44) studies reported statistically significant association (p value < 0.05) between PCT and severity.Procalcitonin appears as a promising prognostic biomarker of COVID-19 progression in conjunction with the clinical context.CONCLUSIONProcalcitonin appears as a promising prognostic biomarker of COVID-19 progression in conjunction with the clinical context.Ahmed S, Jafri L, Hoodbhoy Z, Siddiqui I. Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review. Indian J Crit Care Med 2021;25(1):77-84.HOW TO CITE THIS ARTICLEAhmed S, Jafri L, Hoodbhoy Z, Siddiqui I. Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review. Indian J Crit Care Med 2021;25(1):77-84. This study is aimed at reviewing the published literature on the prognostic role of serum procalcitonin (PCT) in COVID-19 cases. We systematically reviewed the literature available on PubMed, MEDLINE, LitCovid NLM, and WHO: to assess the utility of PCT in prognosis of coronavirus disease. Scrutiny for eligible studies comprising articles that have evaluated the prognostic utility of PCT and data compilation was undertaken by two separate investigators. Original articles in human subjects reporting the prognostic role of PCT in adult COVID-19 patients were included. The Quality in Prognosis Studies (QUIPS) tool was utilized to assess the strength of evidence. Results were reported as narrative syntheses. Out of the total 426 citations, 52 articles passed through screening. The quality of evidence and methodology of included studies was overall acceptable. The total sample size of the studies comprised of 15,296 COVID-19-positive subjects. Majority of the studies were from China, i.e., 40 (77%). The PCT cut-off utilized was 0.05 ng/mL by 18 (35%) studies, followed by 0.5 ng/mL by 9 (17.5%). Eighty five percent ( = 44) studies reported statistically significant association ( value < 0.05) between PCT and severity. Procalcitonin appears as a promising prognostic biomarker of COVID-19 progression in conjunction with the clinical context. Ahmed S, Jafri L, Hoodbhoy Z, Siddiqui I. Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review. Indian J Crit Care Med 2021;25(1):77-84. |
| Author | Hoodbhoy, Zahra Siddiqui, Imran Jafri, Lena Ahmed, Sibtain |
| Author_xml | – sequence: 1 givenname: Sibtain surname: Ahmed fullname: Ahmed, Sibtain organization: Department of Pathology and Laboratory Medicine, The Aga Khan University, Karachi, Pakistan – sequence: 2 givenname: Lena surname: Jafri fullname: Jafri, Lena organization: Department of Pathology and Laboratory Medicine, The Aga Khan University, Karachi, Pakistan – sequence: 3 givenname: Zahra surname: Hoodbhoy fullname: Hoodbhoy, Zahra organization: Department of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan – sequence: 4 givenname: Imran surname: Siddiqui fullname: Siddiqui, Imran organization: Department of Pathology and Laboratory Medicine, The Aga Khan University, Karachi, Pakistan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33603306$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1UMlOwzAU9KGILvAL4CMXw7OTODW3qhSoVKmFQq-R47ygVIldYgfUvyeIIo00h1k0mjEZWGeRkGsOtwlAcrc_sL3rWqtrzzhAypmIUpADMgKVCpYIoYZk7P0eQEgl-DkZRpGEKAI5Ii-b1n1Y50Nl6E7XHVJX0i22XUN7xejaVMHZytIe8_Vu-cC4ohsdKrTB39MZ3R59wEb_5l_xq8LvC3JW9lPw8sQT8v64eJs_s9X6aTmfrZiJeRqYSmQRa1mCisspmFiZGPK8AJSYA0fBue71qUFdclS8ADkFoZQpSl0alFxMyM1f76F1nx36kDWVN1jX2qLrfCZixVXMZap669XJ2uUNFtmhrRrdHrP_G8QPuDVhzw |
| CitedBy_id | crossref_primary_10_5005_jp_journals_10071_23967 crossref_primary_10_1016_j_jtho_2021_12_015 crossref_primary_10_3389_fcimb_2022_1038908 crossref_primary_10_3390_chemosensors9070182 crossref_primary_10_1016_j_jmii_2023_06_001 crossref_primary_10_7759_cureus_56197 crossref_primary_10_3390_v17030357 crossref_primary_10_3390_arm93040022 crossref_primary_10_3390_v15071511 crossref_primary_10_2478_rrlm_2023_0004 crossref_primary_10_3389_fendo_2021_727320 crossref_primary_10_1097_MRM_0000000000000334 crossref_primary_10_1016_j_cyto_2025_156867 crossref_primary_10_1016_j_ijid_2022_03_044 crossref_primary_10_3390_microorganisms12071443 crossref_primary_10_1038_s41598_023_39268_2 crossref_primary_10_1177_21501319231206911 crossref_primary_10_5937_jomb0_33962 crossref_primary_10_1371_journal_pone_0272840 crossref_primary_10_3390_cells10113098 crossref_primary_10_5005_jp_journals_10071_24309 crossref_primary_10_3390_app122312180 crossref_primary_10_1371_journal_pone_0284520 crossref_primary_10_1016_j_cegh_2022_101044 crossref_primary_10_2478_jccm_2023_0030 crossref_primary_10_31965_infokes_Vol20_Iss1_638 crossref_primary_10_2147_IJGM_S334544 |
| ContentType | Journal Article |
| Copyright | Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd. |
| Copyright_xml | – notice: Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd. |
| DBID | NPM 7X8 |
| DOI | 10.5005/jp-journals-10071-23706 |
| DatabaseName | PubMed MEDLINE - Academic |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| ExternalDocumentID | 33603306 |
| Genre | Journal Article Review |
| GroupedDBID | --- 29I 2WC 53G 5GY 5VS 7X7 8FI 8FJ 8G5 AAWTL ABDBF ABUWG ABVJJ ACGFO ACGFS ACIHN ACUHS ADBBV ADRAZ AEAQA AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC B0M BAWUL BENPR BPHCQ BVXVI C1A CCPQU DIK DU5 DWQXO E3Z EAD EAP EBD EBS EJD EMK EOJEC EPL ESX F5P FRP FYUFA GNUQQ GUQSH GX1 H13 HMCUK HYE IAO IEA IHE IHR IHW IL9 IOF IPO ITC KQ8 M2O M48 NPM O5R O5S OBODZ OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC RBI RNS RPM TR2 TUS UKHRP W2D XSB ~8M 7X8 |
| ID | FETCH-LOGICAL-c417t-956d4a6f094f80c49c40bbd0e6eb01e211ad4a8ceaf1e91d0680299cdfafce612 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 33 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000608404100017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0972-5229 |
| IngestDate | Fri Sep 05 12:18:09 EDT 2025 Mon Jul 21 05:30:03 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 1 |
| Keywords | COVID-19 Systematic review Procalcitonin Prognostic biomarker |
| Language | English |
| License | Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c417t-956d4a6f094f80c49c40bbd0e6eb01e211ad4a8ceaf1e91d0680299cdfafce612 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://doi.org/10.5005/jp-journals-10071-23706 |
| PMID | 33603306 |
| PQID | 2491941679 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2491941679 pubmed_primary_33603306 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-01-01 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | India |
| PublicationPlace_xml | – name: India |
| PublicationTitle | Indian journal of critical care medicine |
| PublicationTitleAlternate | Indian J Crit Care Med |
| PublicationYear | 2021 |
| SSID | ssj0026921 |
| Score | 2.3688715 |
| SecondaryResourceType | review_article |
| Snippet | This study is aimed at reviewing the published literature on the prognostic role of serum procalcitonin (PCT) in COVID-19 cases.
We systematically reviewed the... This study is aimed at reviewing the published literature on the prognostic role of serum procalcitonin (PCT) in COVID-19 cases.BACKGROUNDThis study is aimed... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 77 |
| Title | Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33603306 https://www.proquest.com/docview/2491941679 |
| Volume | 25 |
| WOSCitedRecordID | wos000608404100017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwEA_qRHzx-2N-EcHXsCbN-uGLjOlQcLOijr2VJE1gMtu6bv79XtpuPgmCUPoSQktyubvf_S53CF0lhnHNjEPA-zCEg8EmkrqScCNY6DPhJ2XFm-GjPxgEo1EY1QG3ok6rXOjEUlEnmbIx8hbABMDbljS4yT-J7Rpl2dW6hcYqarjgylip9kdLFoF5YXnvylaoAcDFwiq_qw2C13rPSb1ZBbGJApQw13e83_3M0t70tv_7pztoq_Y0cacSjV20otM9tNGvufR99BxNM5tlB8N4KCZzjTODQXXMP7C9PSAmCg57Ok4xPN2n4cMtoSGOqjKsxTXu4JdlEWhcMQwH6K1399q9J3WDBaI49WcEsFHChWcA4pnAUTxU3JEycbSnpUM1YEMB44HSwlAd0sT26QDzpRIjjNLgGx2itTRL9THChiouuK8CAwBFMi7hC54Gf6AtqXRdr4kuF4sVgwBbVkKkOpsX8c9yNdFRteJxXlXaiGGi4wKoOfnD7FO0yWy-SRkeOUMNA1urz9G6-pqNi-lFKRnwHkT9b7yfwnk |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+Value+of+Serum+Procalcitonin+in+COVID-19+Patients%3A+A+Systematic+Review&rft.jtitle=Indian+journal+of+critical+care+medicine&rft.au=Ahmed%2C+Sibtain&rft.au=Jafri%2C+Lena&rft.au=Hoodbhoy%2C+Zahra&rft.au=Siddiqui%2C+Imran&rft.date=2021-01-01&rft.issn=0972-5229&rft.volume=25&rft.issue=1&rft.spage=77&rft_id=info:doi/10.5005%2Fjp-journals-10071-23706&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0972-5229&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0972-5229&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0972-5229&client=summon |